| Year |
Citation |
Score |
| 2020 |
Ambaw YA, Fuchs D, Raida M, Mazengia NT, Torta F, Wheelock CE, Wenk MR, Tong L. Changes of tear lipid mediators after eyelid warming or thermopulsation treatment for meibomian gland dysfunction. Prostaglandins & Other Lipid Mediators. 106474. PMID 32783924 DOI: 10.1016/J.Prostaglandins.2020.106474 |
0.305 |
|
| 2020 |
Wheelock CE, Strandvik B. Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 160: 102156. PMID 32750662 DOI: 10.1016/J.Plefa.2020.102156 |
0.307 |
|
| 2020 |
Meuronen T, Lankinen MA, Fauland A, Shimizu BI, de Mello VD, Laaksonen DE, Wheelock CE, Erkkilä AT, Schwab US. Intake of Camelina Sativa Oil and Fatty Fish Alter the Plasma Lipid Mediator Profile in Subjects with Impaired Glucose Metabolism - A Randomized Controlled Trial. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 159: 102143. PMID 32512364 DOI: 10.1016/J.Plefa.2020.102143 |
0.314 |
|
| 2020 |
López-Vicario C, Checa A, Urdangarin A, Aguilar F, Alcaraz-Quiles J, Caraceni P, Amorós A, Pavesi M, Gómez-Cabrero D, Trebicka J, Oettl K, Moreau R, Planell N, Arroyo V, Wheelock CE, et al. Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis. Journal of Hepatology. PMID 32294533 DOI: 10.1016/J.Jhep.2020.03.046 |
0.329 |
|
| 2020 |
Fuchs D, Tang X, Johnsson AK, Dahlén SE, Hamberg M, Wheelock CE. Eosinophils synthesize trihydroxyoctadecenoic acids (TriHOMEs) via a 15-lipoxygenase dependent process. Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids. 158611. PMID 31918007 DOI: 10.1016/J.Bbalip.2020.158611 |
0.352 |
|
| 2019 |
Bergqvist F, Ossipova E, Idborg H, Raouf J, Checa A, Englund K, Englund P, Khoonsari PE, Kultima K, Wheelock CE, Larsson K, Korotkova M, Jakobsson PJ. Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells. Frontiers in Pharmacology. 10: 636. PMID 31231223 DOI: 10.3389/Fphar.2019.00636 |
0.338 |
|
| 2018 |
Garreta-Lara E, Checa A, Fuchs D, Tauler R, Lacorte S, Wheelock CE, Barata C. Effect of psychiatric drugs on Daphnia magna oxylipin profiles. The Science of the Total Environment. 644: 1101-1109. PMID 30743823 DOI: 10.1016/J.Scitotenv.2018.06.333 |
0.344 |
|
| 2018 |
Reinke SN, Galindo-Prieto B, Skotare T, Broadhurst DI, Singhania A, Horowitz D, Djukanovic R, Hinks TSC, Geladi P, Trygg J, Wheelock CE. OnPLS-based multi-block data integration: a multivariate approach to interrogating biological interactions in asthma. Analytical Chemistry. PMID 30335973 DOI: 10.1021/Acs.Analchem.8B03205 |
0.317 |
|
| 2018 |
Dyczynski M, Vesterlund M, Björklund AC, Zachariadis V, Janssen J, Gallart-Ayala H, Daskalaki E, Wheelock CE, Lehtiö J, Grandér D, Tamm KP, Nilsson R. Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment. Cell Death & Disease. 9: 846. PMID 30154400 DOI: 10.1038/S41419-018-0625-7 |
0.305 |
|
| 2018 |
Kolmert J, Piñeiro-Hermida S, Wheelock CE, Hamberg M, Gregory JA, López IP, Fauland A, Dahlén SE, Pichel JG, Adner M. Prominent release of lipoxygenase generated mediators in a murine house dust mite-induced asthma model. Prostaglandins & Other Lipid Mediators. PMID 29763661 DOI: 10.1016/J.Prostaglandins.2018.05.005 |
0.337 |
|
| 2018 |
Laguna-Fernandez A, Checa A, Carracedo M, Artiach G, Petri MH, Baumgartner R, Forteza MJ, Jiang X, Andonova T, Walker ME, Dalli J, Arnardottir H, Gisterå A, Thul S, Wheelock CE, et al. ERV1/ChemR23 Signaling Protects from Atherosclerosis by Modifying oxLDL Uptake and Phagocytosis in Macrophages. Circulation. PMID 29739755 DOI: 10.1161/Circulationaha.117.032801 |
0.337 |
|
| 2018 |
Lazarinis N, Bood J, Gomez C, Kolmert J, Lantz AS, Gyllfors P, Davis A, Wheelock CE, Dahlén SE, Dahlén B. Leukotriene Einduces airflow obstruction and mast cell activation via the CysLTreceptor. The Journal of Allergy and Clinical Immunology. PMID 29518425 DOI: 10.1016/J.Jaci.2018.02.024 |
0.307 |
|
| 2017 |
García-Flores LA, Medina S, Gómez C, Wheelock CE, Cejuela R, Martínez-Sanz JM, Oger C, Galano JM, Durand T, Hernández-Sáez Á, Ferreres F, Gil-Izquierdo Á. Aronia-citrus juice (polyphenol-rich juice) intake and elite triathlon training: a lipidomic approach using representative oxylipins in urine. Food & Function. PMID 29231216 DOI: 10.1039/C7Fo01409K |
0.302 |
|
| 2017 |
Araujo AC, Wheelock CE, Haeggström JZ. The eicosanoids, redox regulated lipid mediators in immunometabolic disorders. Antioxidants & Redox Signaling. PMID 28978222 DOI: 10.1089/Ars.2017.7332 |
0.326 |
|
| 2017 |
Reinke SN, Gallart-Ayala H, Gómez C, Checa A, Fauland A, Naz S, Kamleh MA, Djukanović R, Hinks TS, Wheelock CE. Metabolomics analysis identifies different metabotypes of asthma severity. The European Respiratory Journal. 49. PMID 28356371 DOI: 10.1183/13993003.01740-2016 |
0.317 |
|
| 2017 |
Wheelock C, Naz S, Reinke S, Chaleckis R, Schofield J, Skipp P, Bigler J, Loza M, Baribaud F, Bakke P, Caruso M, Chanez P, Fowler S, Horvath K, Krug N, et al. Urinary metabolomics-based molecular sub-phenotyping of the U-BIOPRED asthma cohort European Respiratory Journal. 50. DOI: 10.1183/1393003.Congress-2017.Pa4939 |
0.3 |
|
| 2016 |
Balgoma D, Yang M, Sjödin M, Snowden S, Karimi R, Levänen B, Merikallio H, Kaarteenaho R, Palmberg L, Larsson K, Erle DJ, Dahlén SE, Dahlén B, Sköld CM, Wheelock ÅM, ... Wheelock CE, et al. Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD. The European Respiratory Journal. PMID 26965288 DOI: 10.1183/13993003.01080-2015 |
0.323 |
|
| 2016 |
Frei RB, Luschnig P, Parzmair GP, Peinhaupt M, Schranz S, Fauland A, Wheelock CE, Heinemann A, Sturm EM. Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice. Allergy. PMID 26850094 DOI: 10.1111/All.12858 |
0.316 |
|
| 2016 |
Mazein A, Meulder BD, Lefaudeux D, Wheelock C, Dahlen S, Knowles RG, Bigler J, Sterk PJ, Auffray C. LSC Abstract – Eicosanoids in asthma: Multi-omics data interpretation European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Op2 |
0.309 |
|
| 2016 |
Lazarinis N, Bood J, Gomez C, Kolmert J, Säfholm J, Lantz A, Henriksson E, Wheelock C, Dahlén S, Dahlén B. The CysLT1receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4in subjects with asthma European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Oa1983 |
0.316 |
|
| 2016 |
Checa A, Idborg H, Sar DG, Jakobsson P, Wheelock C, Gunnarsson I. A6.14 Dysregulations in the sphingolipid pathway in sle patients Annals of the Rheumatic Diseases. 75: A53.1-A53. DOI: 10.1136/Annrheumdis-2016-209124.126 |
0.316 |
|
| 2015 |
Checa A, Holm T, Sjödin MO, Reinke SN, Alm J, Scheynius A, Wheelock CE. Lipid mediator profile in vernix caseosa reflects skin barrier development. Scientific Reports. 5: 15740. PMID 26521946 DOI: 10.1038/Srep15740 |
0.319 |
|
| 2015 |
Kamleh MA, Snowden SG, Grapov D, Blackburn GJ, Watson DG, Xu N, Ståhle M, Wheelock CE. LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment. Journal of Proteome Research. 14: 557-66. PMID 25361234 DOI: 10.1021/Pr500782G |
0.334 |
|
| 2015 |
Brannan JD, Bood J, Alkhabaz A, Balgoma D, Otis J, Delin I, Dahlén B, Wheelock CE, Nair P, Dahlén SE, O'Byrne PM. The effect of omega-3 fatty acids on bronchial hyperresponsiveness, sputum eosinophilia, and mast cell mediators in asthma. Chest. 147: 397-405. PMID 25321659 DOI: 10.1378/Chest.14-1214 |
0.304 |
|
| 2015 |
Balgoma D, Yang M, Sjodin M, Snowden S, Karimi R, Levanen B, Merikallio H, Kaarteenaho R, Palmberg L, Larsson K, Erle D, Dahlen S, Dahlen B, Skold M, Wheelock A, ... Wheelock C, et al. LATE-BREAKING ABSTRACT: Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa851 |
0.325 |
|
| 2014 |
Snowden SG, Grapov D, Settergren M, D'Alexandri FL, Haeggström JZ, Fiehn O, Hyötyläinen T, Pedersen TL, Newman JW, Oreši? M, Pernow J, Wheelock CE. High-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapy. Circulation. Cardiovascular Genetics. 7: 955-64. PMID 25516625 DOI: 10.1161/Circgenetics.114.000606 |
0.529 |
|
| 2014 |
Larsson N, Lundström SL, Pinto R, Rankin G, Karimpour M, Blomberg A, Sandström T, Pourazar J, Trygg J, Behndig AF, Wheelock CE, Nording ML. Lipid mediator profiles differ between lung compartments in asthmatic and healthy humans. The European Respiratory Journal. 43: 453-63. PMID 24036245 DOI: 10.1183/09031936.00209412 |
0.33 |
|
| 2014 |
Idborg H, Raouf J, Ossipova E, Checa A, Olsson P, Leclerc P, Oliynik G, Wheelock C, Jakobsson P, Korotkova M. A9.6 Effect of mPGES-1 targeting on lipid metabolism in human cells Annals of the Rheumatic Diseases. 73: A94.1-A94. DOI: 10.1136/Annrheumdis-2013-205124.218 |
0.365 |
|
| 2014 |
Idborg H, Checa A, Sar D, Jakobsson P, Wheelock C, Gunnarsson I. A3.28 Screening of sphingolipids in SLE – before and after treatment Annals of the Rheumatic Diseases. 73. DOI: 10.1136/Annrheumdis-2013-205124.121 |
0.302 |
|
| 2013 |
Balgoma D, Larsson J, Rokach J, Lawson JA, Daham K, Dahlén B, Dahlén SE, Wheelock CE. Quantification of lipid mediator metabolites in human urine from asthma patients by electrospray ionization mass spectrometry: controlling matrix effects. Analytical Chemistry. 85: 7866-74. PMID 23863083 DOI: 10.1021/Ac401461B |
0.307 |
|
| 2013 |
Balgoma D, Checa A, Sar DG, Snowden S, Wheelock CE. Quantitative metabolic profiling of lipid mediators. Molecular Nutrition & Food Research. 57: 1359-77. PMID 23828856 DOI: 10.1002/Mnfr.201200840 |
0.342 |
|
| 2013 |
Lundström SL, Yang J, Brannan JD, Haeggström JZ, Hammock BD, Nair P, O'Byrne P, Dahlén SE, Wheelock CE. Lipid mediator serum profiles in asthmatics significantly shift following dietary supplementation with omega-3 fatty acids. Molecular Nutrition & Food Research. 57: 1378-89. PMID 23824870 DOI: 10.1002/Mnfr.201200827 |
0.439 |
|
| 2013 |
Lundström SL, Saluja R, Adner M, Haeggström JZ, Nilsson G, Wheelock CE. Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations. Journal of Lipid Research. 54: 116-26. PMID 23034214 DOI: 10.1194/Jlr.M030171 |
0.341 |
|
| 2012 |
Kirwan GM, Johansson E, Kleemann R, Verheij ER, Wheelock Ã…M, Goto S, Trygg J, Wheelock CE. Building multivariate systems biology models. Analytical Chemistry. 84: 7064-71. PMID 22856472 DOI: 10.1021/Ac301269R |
0.307 |
|
| 2012 |
Diez D, Goto S, Fahy JV, Erle DJ, Woodruff PG, Wheelock Ã…M, Wheelock CE. Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmatics. Bmc Medical Genomics. 5: 27. PMID 22713245 DOI: 10.1186/1755-8794-5-27 |
0.305 |
|
| 2012 |
Lundström SL, Yang J, Källberg HJ, Thunberg S, Gafvelin G, Haeggström JZ, Grönneberg R, Grunewald J, van Hage M, Hammock BD, Eklund A, Wheelock ÅM, Wheelock CE. Allergic asthmatics show divergent lipid mediator profiles from healthy controls both at baseline and following birch pollen provocation. Plos One. 7: e33780. PMID 22438998 DOI: 10.1371/Journal.Pone.0033780 |
0.467 |
|
| 2011 |
Lundström SL, Levänen B, Nording M, Klepczynska-Nyström A, Sköld M, Haeggström JZ, Grunewald J, Svartengren M, Hammock BD, Larsson BM, Eklund A, Wheelock ÅM, Wheelock CE. Asthmatics exhibit altered oxylipin profiles compared to healthy individuals after subway air exposure. Plos One. 6: e23864. PMID 21897859 DOI: 10.1371/Journal.Pone.0023864 |
0.442 |
|
| 2011 |
Lundström SL, Balgoma D, Wheelock ÅM, Haeggström JZ, Dahlén SE, Wheelock CE. Lipid mediator profiling in pulmonary disease. Current Pharmaceutical Biotechnology. 12: 1026-52. PMID 21466458 DOI: 10.2174/138920111795909087 |
0.344 |
|
| 2011 |
Gertow K, Nobili E, Folkersen L, Newman JW, Pedersen TL, Ekstrand J, Swedenborg J, Kühn H, Wheelock CE, Hansson GK, Hedin U, Haeggström JZ, Gabrielsen A. 12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms. Atherosclerosis. 215: 411-6. PMID 21316676 DOI: 10.1016/J.Atherosclerosis.2011.01.015 |
0.499 |
|
| 2010 |
Haeggström JZ, Rinaldo-Matthis A, Wheelock CE, Wetterholm A. Advances in eicosanoid research, novel therapeutic implications. Biochemical and Biophysical Research Communications. 396: 135-9. PMID 20494126 DOI: 10.1016/J.Bbrc.2010.03.140 |
0.304 |
|
| 2009 |
Wheelock CE, Wheelock AM, Kawashima S, Diez D, Kanehisa M, van Erk M, Kleemann R, Haeggström JZ, Goto S. Systems biology approaches and pathway tools for investigating cardiovascular disease. Molecular Biosystems. 5: 588-602. PMID 19462016 DOI: 10.1039/B902356A |
0.325 |
|
| 2009 |
Harada T, Nakagawa Y, Wadkins RM, Potter PM, Wheelock CE. Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis. Bioorganic & Medicinal Chemistry. 17: 149-64. PMID 19062296 DOI: 10.1016/J.Bmc.2008.11.008 |
0.369 |
|
| 2008 |
Wheelock CE, Phillips BM, Anderson BS, Miller JL, Miller MJ, Hammock BD. Applications of carboxylesterase activity in environmental monitoring and toxicity identification evaluations (TIEs). Reviews of Environmental Contamination and Toxicology. 195: 117-78. PMID 18418956 DOI: 10.1007/978-0-387-77030-7_5 |
0.446 |
|
| 2008 |
Morisseau C, Newman JW, Wheelock CE, Hill Iii T, Morin D, Buckpitt AR, Hammock BD. Development of metabolically stable inhibitors of Mammalian microsomal epoxide hydrolase. Chemical Research in Toxicology. 21: 951-7. PMID 18363382 DOI: 10.1021/Tx700446U |
0.624 |
|
| 2008 |
Wheelock CE, Colvin ME, Sanborn JR, Hammock BD. Substituted 3-phenylpropenoates and related analogs: electron ionization mass spectral fragmentation and density functional theory calculations. Journal of Mass Spectrometry : Jms. 43: 1053-62. PMID 18286670 DOI: 10.1002/Jms.1384 |
0.374 |
|
| 2008 |
Wheelock CE, Forshed J, Goto S, Hammock BD, Newman JW. Effects of pyridine exposure upon structural lipid metabolism in Swiss Webster mice. Chemical Research in Toxicology. 21: 583-90. PMID 18251509 DOI: 10.1021/Tx7002454 |
0.596 |
|
| 2008 |
Wheelock CE, Nishi K, Ying A, Jones PD, Colvin ME, Olmstead MM, Hammock BD. Influence of sulfur oxidation state and steric bulk upon trifluoromethyl ketone (TFK) binding kinetics to carboxylesterases and fatty acid amide hydrolase (FAAH). Bioorganic & Medicinal Chemistry. 16: 2114-30. PMID 18023188 DOI: 10.1016/J.Bmc.2007.10.081 |
0.447 |
|
| 2007 |
Wheelock CE, Goto S, Hammock BD, Newman JW. Clofibrate-induced changes in the liver, heart, brain and white adipose lipid metabolome of Swiss-Webster mice. Metabolomics : Official Journal of the Metabolomic Society. 3: 137-145. PMID 19079556 DOI: 10.1007/S11306-007-0052-8 |
0.556 |
|
| 2007 |
Kadowaki T, Wheelock CE, Adachi T, Kudo T, Okamoto S, Tanaka N, Tonomura K, Tsujimoto G, Mamitsuka H, Goto S, Kanehisa M. Identification of endocrine disruptor biodegradation by integration of structure-activity relationship with pathway analysis. Environmental Science & Technology. 41: 7997-8003. PMID 18186328 DOI: 10.1021/Es062751S |
0.315 |
|
| 2007 |
Hillard CJ, Ho WS, Thompson J, Gauthier KM, Wheelock CE, Huang H, Hammock BD. Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. British Journal of Pharmacology. 152: 691-8. PMID 17891162 DOI: 10.1038/Sj.Bjp.0707468 |
0.405 |
|
| 2007 |
Endsley MP, Aggarwal N, Isbell MA, Wheelock CE, Hammock BD, Falck JR, Campbell WB, Nithipatikom K. Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism. International Journal of Cancer. Journal International Du Cancer. 121: 984-91. PMID 17443494 DOI: 10.1002/Ijc.22761 |
0.398 |
|
| 2007 |
Wadkins RM, Hyatt JL, Edwards CC, Tsurkan L, Redinbo MR, Wheelock CE, Jones PD, Hammock BD, Potter PM. Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compounds. Molecular Pharmacology. 71: 713-23. PMID 17167034 DOI: 10.1124/Mol.105.021683 |
0.455 |
|
| 2006 |
Wheelock CE, Miller JL, Miller MJ, Phillips BM, Huntley SA, Gee SJ, Tjeerdema RS, Hammock BD. Use of carboxylesterase activity to remove pyrethroid-associated toxicity to Ceriodaphnia dubia and Hyalella azteca in toxicity identification evaluations. Environmental Toxicology and Chemistry / Setac. 25: 973-84. PMID 16629136 DOI: 10.1897/05-334R.1 |
0.405 |
|
| 2006 |
Wogulis M, Wheelock CE, Kamita SG, Hinton AC, Whetstone PA, Hammock BD, Wilson DK. Structural studies of a potent insect maturation inhibitor bound to the juvenile hormone esterase of Manduca sexta. Biochemistry. 45: 4045-57. PMID 16566578 DOI: 10.1021/Bi0521644 |
0.694 |
|
| 2005 |
Kang KD, Jones PD, Huang H, Zhang R, Mostovich LA, Wheelock CE, Watanabe T, Gulyaeva LF, Hammock BD. Evaluation of alpha-cyano ethers as fluorescent substrates for assay of cytochrome P450 enzyme activity. Analytical Biochemistry. 344: 183-92. PMID 16083846 DOI: 10.1016/J.Ab.2005.06.032 |
0.401 |
|
| 2005 |
Wheelock CE, Eder KJ, Werner I, Huang H, Jones PD, Brammell BF, Elskus AA, Hammock BD. Individual variability in esterase activity and CYP1A levels in Chinook salmon (Oncorhynchus tshawytscha) exposed to esfenvalerate and chlorpyrifos. Aquatic Toxicology (Amsterdam, Netherlands). 74: 172-92. PMID 16011852 DOI: 10.1016/J.Aquatox.2005.05.009 |
0.432 |
|
| 2005 |
Wheelock CE, Miller JL, Miller MJ, Phillips BM, Gee SJ, Tjeerdema RS, Hammock BD. Influence of container adsorption upon observed pyrethroid toxicity to Ceriodaphnia dubia and Hyalella azteca. Aquatic Toxicology (Amsterdam, Netherlands). 74: 47-52. PMID 15951033 DOI: 10.1016/J.Aquatox.2005.04.007 |
0.368 |
|
| 2005 |
Nithipatikom K, Endsley MP, Isbell MA, Wheelock CE, Hammock BD, Campbell WB. A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. Biochemical and Biophysical Research Communications. 332: 1028-33. PMID 15919052 DOI: 10.1016/J.Bbrc.2005.05.049 |
0.402 |
|
| 2005 |
Wheelock CE, Shan G, Ottea J. Overview of carboxylesterases and their role in the metabolism of insecticides Journal of Pesticide Science. 30: 75-83. DOI: 10.1584/Jpestics.30.75 |
0.303 |
|
| 2004 |
Wheelock CE, Miller JL, Miller MJ, Gee SJ, Shan G, Hammock BD. Development of toxicity identification evaluation procedures for pyrethroid detection using esterase activity. Environmental Toxicology and Chemistry / Setac. 23: 2699-708. PMID 15559286 DOI: 10.1897/03-544 |
0.407 |
|
| 2004 |
Stok JE, Goloshchapov A, Song C, Wheelock CE, Derbel MB, Morisseau C, Hammock BD. Investigation of the role of a second conserved serine in carboxylesterases via site-directed mutagenesis. Archives of Biochemistry and Biophysics. 430: 247-55. PMID 15369824 DOI: 10.1016/J.Abb.2004.06.020 |
0.414 |
|
| 2004 |
Stok JE, Huang H, Jones PD, Wheelock CE, Morisseau C, Hammock BD. Identification, expression, and purification of a pyrethroid-hydrolyzing carboxylesterase from mouse liver microsomes. The Journal of Biological Chemistry. 279: 29863-9. PMID 15123619 DOI: 10.1074/Jbc.M403673200 |
0.419 |
|
| 2004 |
McAbee RD, Kang KD, Stanich MA, Christiansen JA, Wheelock CE, Inman AD, Hammock BD, Cornel AJ. Pyrethroid tolerance in Culex pipiens pipiens var molestus from Marin County, California. Pest Management Science. 60: 359-68. PMID 15119598 DOI: 10.1002/Ps.799 |
0.391 |
|
| 2004 |
Lydy M, Belden J, Wheelock C, Hammock B, Denton D. Challenges in Regulating Pesticide Mixtures Ecology and Society. 9. DOI: 10.5751/Es-00694-090601 |
0.362 |
|
| 2003 |
Wheelock CE, Nakagawa Y, Akamatsu M, Hammock BD. Use of classical and 3-D QSAR to examine the hydration state of juvenile hormone esterase inhibitors. Bioorganic & Medicinal Chemistry. 11: 5101-16. PMID 14604674 DOI: 10.1016/J.Bmc.2003.08.023 |
0.45 |
|
| 2003 |
Kamita SG, Hinton AC, Wheelock CE, Wogulis MD, Wilson DK, Wolf NM, Stok JE, Hock B, Hammock BD. Juvenile hormone (JH) esterase: why are you so JH specific? Insect Biochemistry and Molecular Biology. 33: 1261-73. PMID 14599498 DOI: 10.1016/J.Ibmb.2003.08.004 |
0.687 |
|
| 2003 |
Wheelock CE, Wheelock AM, Zhang R, Stok JE, Morisseau C, Le Valley SE, Green CE, Hammock BD. Evaluation of alpha-cyanoesters as fluorescent substrates for examining interindividual variation in general and pyrethroid-selective esterases in human liver microsomes. Analytical Biochemistry. 315: 208-22. PMID 12689831 DOI: 10.1016/S0003-2697(03)00002-2 |
0.414 |
|
| 2003 |
Denton DL, Wheelock CE, Murray SA, Deanovic LA, Hammock BD, Hinton DE. Joint acute toxicity of esfenvalerate and diazinon to larval fathead minnows (Pimephales promelas). Environmental Toxicology and Chemistry / Setac. 22: 336-41. PMID 12558165 DOI: 10.1002/Etc.5620220214 |
0.421 |
|
| 2002 |
Wheelock CE, Colvin ME, Uemura I, Olmstead MM, Sanborn JR, Nakagawa Y, Jones AD, Hammock BD. Use of ab initio calculations to predict the biological potency of carboxylesterase inhibitors. Journal of Medicinal Chemistry. 45: 5576-93. PMID 12459025 DOI: 10.1021/Jm020072W |
0.452 |
|
| 2002 |
Wheelock CE, Baumgartner TA, Newman JW, Wolfe MF, Tjeerdema RS. Effect of nutritional state on Hsp60 levels in the rotifer Brachionus plicatilis following toxicant exposure. Aquatic Toxicology (Amsterdam, Netherlands). 61: 89-93. PMID 12297373 DOI: 10.1016/S0166-445X(02)00044-9 |
0.498 |
|
| 2002 |
Morisseau C, Goodrow MH, Newman JW, Wheelock CE, Dowdy DL, Hammock BD. Structural refinement of inhibitors of urea-based soluble epoxide hydrolases. Biochemical Pharmacology. 63: 1599-608. PMID 12007563 DOI: 10.1016/S0006-2952(02)00952-8 |
0.613 |
|
| 2001 |
Wheelock CE, Severson TF, Hammock BD. Synthesis of new carboxylesterase inhibitors and evaluation of potency and water solubility. Chemical Research in Toxicology. 14: 1563-72. PMID 11743738 DOI: 10.1021/Tx015508+ |
0.455 |
|
| 2001 |
Newman JW, Denton DL, Morisseau C, Koger CS, Wheelock CE, Hinton DE, Hammock BD. Evaluation of fish models of soluble epoxide hydrolase inhibition. Environmental Health Perspectives. 109: 61-6. PMID 11171526 DOI: 10.1289/Ehp.0110961 |
0.589 |
|
| 2001 |
Nakagawa Y, Wheelock CE, Morisseau C, Goodrow MH, Hammock BG, Hammock BD. Erratum to “3-D QSAR Analysis of Inhibition of Murine Soluble Epoxide Hydrolase (MsEH) by Benzoylureas, Arylureas, and their Analogues” Bioorganic & Medicinal Chemistry. 9: 1941. DOI: 10.1016/S0968-0896(01)00096-7 |
0.379 |
|
| 2000 |
Nakagawa Y, Wheelock CE, Morisseau C, Goodrow MH, Hammock BG, Hammock BD. 3-D QSAR analysis of inhibition of murine soluble epoxide hydrolase (MsEH) by benzoylureas, arylureas, and their analogues. Bioorganic & Medicinal Chemistry. 8: 2663-73. PMID 11092551 DOI: 10.1016/S0968-0896(00)00198-X |
0.413 |
|
| Show low-probability matches. |